Masataka Okamoto

4.2k total citations
77 papers, 2.5k citations indexed

About

Masataka Okamoto is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Masataka Okamoto has authored 77 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 39 papers in Oncology and 23 papers in Genetics. Recurrent topics in Masataka Okamoto's work include Lymphoma Diagnosis and Treatment (49 papers), Viral-associated cancers and disorders (27 papers) and CNS Lymphoma Diagnosis and Treatment (16 papers). Masataka Okamoto is often cited by papers focused on Lymphoma Diagnosis and Treatment (49 papers), Viral-associated cancers and disorders (27 papers) and CNS Lymphoma Diagnosis and Treatment (16 papers). Masataka Okamoto collaborates with scholars based in Japan, United States and China. Masataka Okamoto's co-authors include Shigeo Nakamura, Nozomi Niitsu, Ritsuro Suzuki, Motoko Yamaguchi, Masami Hirano, Tadashi Yoshino, Hirokazu Nakamine, Masao Seto, Yasuo Morishima and Masaru Kojima and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Masataka Okamoto

75 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Okamoto Japan 27 1.8k 1.1k 845 738 358 77 2.5k
Ryo Ichinohasama Japan 26 1.6k 0.9× 1.2k 1.1× 413 0.5× 488 0.7× 472 1.3× 154 2.9k
Javier Menárguez Spain 28 1.3k 0.7× 828 0.8× 186 0.2× 572 0.8× 338 0.9× 68 2.2k
Daisuke Niino Japan 21 977 0.5× 961 0.9× 247 0.3× 365 0.5× 654 1.8× 94 1.9k
Giulio Fraternali Orcioni Italy 21 909 0.5× 643 0.6× 225 0.3× 350 0.5× 427 1.2× 81 1.9k
Delphine Rolland United States 17 677 0.4× 598 0.5× 349 0.4× 299 0.4× 291 0.8× 41 2.0k
P. M. Kluin Netherlands 21 1.0k 0.6× 797 0.7× 193 0.2× 431 0.6× 314 0.9× 40 1.8k
Mathias Witzens‐Harig Germany 30 1.1k 0.6× 1.3k 1.2× 341 0.4× 738 1.0× 895 2.5× 136 2.8k
Yasufumi Masaki Japan 26 707 0.4× 813 0.7× 383 0.5× 382 0.5× 271 0.8× 115 2.6k
Anne Lennard United Kingdom 20 831 0.5× 561 0.5× 168 0.2× 562 0.8× 240 0.7× 51 1.6k
Norifumi Tsukamoto Japan 25 706 0.4× 433 0.4× 343 0.4× 561 0.8× 440 1.2× 139 2.1k

Countries citing papers authored by Masataka Okamoto

Since Specialization
Citations

This map shows the geographic impact of Masataka Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Okamoto more than expected).

Fields of papers citing papers by Masataka Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Okamoto. The network helps show where Masataka Okamoto may publish in the future.

Co-authorship network of co-authors of Masataka Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Okamoto. A scholar is included among the top collaborators of Masataka Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Okamoto. Masataka Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abe, Akihiro, Yukiya Yamamoto, Akira Katsumi, et al.. (2020). Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor. Cytogenetic and Genome Research. 160(5). 255–263. 4 indexed citations
2.
3.
Iwaki, Noriko, Yuka Gion, Eisei Kondo, et al.. (2017). Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome. Scientific Reports. 7(1). 42316–42316. 55 indexed citations
4.
Tamura, Kazuo, Yasukazu Kawai, Toru Kiguchi, et al.. (2016). Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol. International Journal of Clinical Oncology. 21(5). 996–1003. 28 indexed citations
5.
Yanada, Masamitsu, Yukiya Yamamoto, Akinao Okamoto, et al.. (2016). TP53 mutations in older adults with acute myeloid leukemia. International Journal of Hematology. 103(4). 429–435. 29 indexed citations
6.
Okamoto, Akinao, Akihiro Abe, Masataka Okamoto, et al.. (2012). Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy. International Journal of Hematology. 96(4). 516–520. 4 indexed citations
7.
Niitsu, Nozomi, Mika Kohri, Yuki Hagiwara, et al.. (2010). Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B‐cell lymphoma. Hematological Oncology. 28(2). 68–74. 9 indexed citations
8.
Shimada, Kazuyuki, Takuhei Murase, Kosei Matsue, et al.. (2010). Central nervous system involvement in intravascular large B‐cell lymphoma: A retrospective analysis of 109 patients. Cancer Science. 101(6). 1480–1486. 80 indexed citations
9.
Niitsu, Nozomi, Masataka Okamoto, Hirokazu Nakamine, & Masami Hirano. (2010). Clinicopathologic correlations of diffuse large B‐cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Science. 101(5). 1309–1313. 58 indexed citations
10.
Imai, Hiroshi, Kazuyuki Shimada, Satoko Shimada, et al.. (2009). Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma. Pathology International. 59(7). 431–437. 17 indexed citations
11.
Niitsu, Nozomi, Masataka Okamoto, Ikuo Miura, & Masami Hirano. (2008). Clinical significance of 8q24/c‐MYC translocation in diffuse large B‐cell lymphoma. Cancer Science. 100(2). 233–237. 40 indexed citations
12.
Niitsu, Nozomi, Masataka Okamoto, Hirokazu Nakamine, et al.. (2008). Clinico‐pathologic features and outcome of Japanese patients with peripheral T‐cell lymphomas. Hematological Oncology. 26(3). 152–158. 32 indexed citations
13.
Niitsu, Nozomi, Masataka Okamoto, Naoya Nakamura, et al.. (2007). Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients. Leukemia Research. 31(9). 1191–1197. 9 indexed citations
14.
Niitsu, Nozomi, Masataka Okamoto, Naoto Tomita, et al.. (2006). Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma. Leukemia & lymphoma. 47(9). 1908–1914. 10 indexed citations
15.
Inagaki, Hiroshi, John K. C. Chan, Mitsukuni Okabe, et al.. (2002). Primary Thymic Extranodal Marginal-Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type Exhibits Distinctive Clinicopathological and Molecular Features. American Journal Of Pathology. 160(4). 1435–1443. 81 indexed citations
16.
Niitsu, Nozomi, Masataka Okamoto, Hirokazu Nakamine, et al.. (2002). Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin‐6 as independent predictors of prognosis in aggressive non‐Hodgkin's lymphoma. European Journal Of Haematology. 68(2). 91–100. 70 indexed citations
17.
Yatabe, Yasushi, Ritsuro Suzuki, Yoshihiro Matsuno, et al.. (2001). Morphological spectrum of cyclin D1‐positive mantle cell lymphoma: Study of 168 cases. Pathology International. 51(10). 747–761. 35 indexed citations
18.
Nakamura, Shigeo, Masato Nagahama, Yoshitoyo Kagami, et al.. (1999). Hodgkin's Disease Expressing Follicular Dendritic Cell Marker CD21 Without Any Other B-cell Marker. The American Journal of Surgical Pathology. 23(4). 363–376. 28 indexed citations
19.
Nakamura, Shigeo, M Shiota, Atsuko Nakagawa, et al.. (1997). Anaplastic Large Cell Lymphoma: A Distinct Molecular Pathologic Entity. The American Journal of Surgical Pathology. 21(12). 1420–1432. 118 indexed citations
20.
Miyazaki, Hitoshi, Fumio Maruyama, Masataka Okamoto, et al.. (1991). Mixed Lymphocyte-Autologous Tumor Cell Reaction in Hematological Malignancies—Effect of Interferon-β and Correlation with the Expression of MHC Class I Antigen on Tumor Cells. Journal of Interferon Research. 11(5). 305–310. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryo Ichinohasama Breakdown of academic impact, for papers by Javier Menárguez Breakdown of academic impact, for papers by Daisuke Niino Breakdown of academic impact, for papers by Giulio Fraternali Orcioni Breakdown of academic impact, for papers by Delphine Rolland Breakdown of academic impact, for papers by P. M. Kluin Breakdown of academic impact, for papers by Mathias Witzens‐Harig Breakdown of academic impact, for papers by Yasufumi Masaki Breakdown of academic impact, for papers by Anne Lennard Breakdown of academic impact, for papers by Norifumi Tsukamoto
Rankless by CCL
2026